Raama Finance has allotted 1.01 crore equity shares at ₹4.80 each upon warrant conversion, raising ₹4.87 crore in capital. The company also appointed M/s. Kumar Gaurav & Co. as its new statutory auditor to fill a casual vacancy.
Raama Finance Expands Capital Base via Warrant Conversion
1,01,50,000 equity shares issued to warrant holders.
Paid-up share capital increases to 10,10,12,000 shares.
Reader Takeaway: Capital infusion strengthens balance sheet, while auditor change signals a standard governance transition for the firm.
What just happened
Raama Finance announced the successful conversion of 1.01 crore warrants into fully paid-up equity shares. Each warrant was converted at an issue price of ₹4.80, resulting in a total capital infusion of ₹4.87 crore for the company. This move has pushed the total paid-up share capital from 9.08 crore shares to 10.10 crore shares.
Why this matters
The conversion of warrants provides the company with immediate liquidity, which can be utilized for operational requirements or debt reduction. For investors, this event signifies a direct change in the capital structure, leading to equity dilution for existing shareholders. Simultaneously, the company has addressed a governance requirement by appointing M/s. Kumar Gaurav & Co. as the new statutory auditor following the resignation of the previous auditor, M/s. Goyal Nagpal and Co.
Risks to watch
The primary consideration for investors is the impact of dilution on earnings per share (EPS). Furthermore, the appointment of the new auditor is currently filling a casual vacancy; shareholders should watch for formal confirmation at the 34th Annual General Meeting in 2027 to ensure smooth regulatory continuity.
What to track next
Investors should monitor the upcoming financial results to observe the company's performance post-infusion and confirm the final regulatory approval of the new audit firm at the next shareholder meeting.